- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07467005
Video Double-Lumen Tube for Secondary Pulmonary Resection
March 9, 2026 updated by: Diansan Su, Zhejiang University
Video Double-Lumen Tube for Secondary Pulmonary Resection: A Multicenter Randomized Controlled Trial
During thoracic surgery, double-lumen endotracheal intubation with one-lung ventilation is routinely performed to optimize surgical exposure, facilitate operative manipulation, and prevent iatrogenic lung injury.
In patients undergoing repeat pulmonary surgery, prior lung resection may lead to pleural adhesions and tracheobronchial distortion, which substantially increase the difficulty of bronchial intubation.
Even with experienced operators, the malposition rate of conventional double-lumen tubes remains high.
The video double-lumen tube enables continuous visualization of the trachea and carina during insertion, positioning, and one-lung ventilation, allowing real-time airway monitoring.
However, no clinical studies have specifically investigated airway management in patients undergoing redo pulmonary surgery.
This study aimed to evaluate the efficacy and safety of the video double-lumen tube during anesthesia in patients undergoing secondary pulmonary resection.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Diansan Su
- Phone Number: +86 18616514088
- Email: diansansu@yahoo.com
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Zhejiang Cancer Hospital
-
Contact:
- Pingbo Xu
- Phone Number: +86 15700074964
- Email: xupingboshanghai@163.com
-
Hangzhou, Zhejiang, China, 310000
- The First Affiliated Hospital, Zhejiang University School of Medicine
-
Contact:
- Diansan Su
- Phone Number: +86 18616514088
- Email: diansansu@yahoo.com
-
Yiwu, Zhejiang, China, 322000
- The Fourth Affiliated Hospital, Zhejiang University School of Medicine
-
Contact:
- Jianhong Xu
- Phone Number: +86 17280781160
- Email: 1197058@zju.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥18 years.
- History of previous pulmonary resection.
- Scheduled for elective pulmonary surgery.
- Planned to receive a left-sided double-lumen tube.
- ASA physical status I-III.
- Patients have signed the informed consent form.
Exclusion Criteria:
- Preoperatively predicted difficult airway (Mallampati ≥ III, Cormack-Lehane ≥ III).
- Acute respiratory distress syndrome (ARDS) or respiratory failure within the past 3 months.
- Uncontrolled asthma.
- Confirmed pregnancy or current breastfeeding.
- Multiple traumatic injuries.
- Current participation in another clinical trial.
- Other conditions deemed unsuitable by the investigator.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Video Double-Lumen Tube Group
|
Use the video double-lumen tube to perform left bronchial intubation under real-time visualization and continuously monitor its position.
|
|
Active Comparator: Conventional Double-Lumen Tube
|
Insert a conventional left-sided double-lumen tube using standard intubation techniques.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Success rate of first-attempt bronchial intubation
Time Frame: During the first intubation attempt
|
During the first intubation attempt
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intubation time
Time Frame: Measured from insertion of the video laryngoscope into the mouth until confirmation of correct tube position
|
Measured from insertion of the video laryngoscope into the mouth until confirmation of correct tube position
|
|
Requirement for and number of fiberoptic bronchoscopy uses
Time Frame: During the entire intraoperative period
|
During the entire intraoperative period
|
|
Frequency of intraoperative tube repositioning
Time Frame: During the entire intraoperative period
|
During the entire intraoperative period
|
|
Surgeon's rating of lung collapse quality
Time Frame: During the entire intraoperative period
|
During the entire intraoperative period
|
|
Incidence of difficult intubation
Time Frame: At the time of intubation
|
At the time of intubation
|
|
Intubation-related adverse events
Time Frame: From the start of intubation until 24 hours postoperatively
|
From the start of intubation until 24 hours postoperatively
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of intraoperative hypoxemia
Time Frame: During the entire intraoperative period
|
During the entire intraoperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 16, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 5, 2027
Study Registration Dates
First Submitted
March 9, 2026
First Submitted That Met QC Criteria
March 9, 2026
First Posted (Actual)
March 12, 2026
Study Record Updates
Last Update Posted (Actual)
March 12, 2026
Last Update Submitted That Met QC Criteria
March 9, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZJU2025B0593
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IV Lung Cancer | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
Clinical Trials on Video Double-Lumen Tube Group
-
Medical University of SilesiaCompletedPredictive Value of Tests | Intubation;DifficultPoland
-
Diansan SuNingbo No.2 Hospital; Affiliated Hospital of Jiaxing UniversityNot yet recruitingThoracoscopic Surgery | Double Lumen Tube IntubationChina
-
Seoul National University HospitalUnknownPreventing Blood Leakage of Bronchial CuffKorea, Republic of
-
M.D. Anderson Cancer CenterE.T. View Medical LtdCompleted
-
Kayseri City HospitalCompletedLung Diseases | Lung CancerTurkey
-
University of Texas Southwestern Medical CenterCompletedSingle Lung Ventilation | Double Lumen Endotracheal TubeUnited States
-
International Institute of Rescue Research and...Unknown
-
Lazarski UniversityCompletedIntubation; Difficult or Failed | Difficult Airway | Intubation;DifficultPoland
-
Rambam Health Care CampusCompletedEndotracheal Intubation | Airway Management | One Lung Ventilation
-
Rennes University HospitalCompletedPancreaticoduodenectomy | Digestive System Surgical ProcedureFrance